Literature DB >> 19909861

Advances in absorbable biomaterials and nasal packing.

Rowan Valentine1, Peter-John Wormald, Raj Sindwani.   

Abstract

Absorbable biomaterials are commonly used after endoscopic sinus surgery, both for hemostatic and wound healing considerations. Although removable nasal packing is the traditional method of controlling ongoing bleeding and modulating wound healing, it is uncomfortable for patients and associated with several complications. Currently available absorbable agents frequently incite an inflammatory reaction and have been shown in animal and human trials to adversely affect the wound healing process. Newer agents offer distinct advantages because of their unique composition and rapid clearance profiles. The selection of packing material used in any given sinus procedure should be based on surgeon preference and the details of the specific case.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19909861     DOI: 10.1016/j.otc.2009.07.009

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  12 in total

1.  Comparison between Gelfoam packing and no packing after endoscopic sinus surgery in the same patients.

Authors:  Jee Hye Wee; Chul Hee Lee; Chae Seo Rhee; Jeong-Whun Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-28       Impact factor: 2.503

2.  Application of new packing material in endoscopic nasal surgery.

Authors:  Haiying Yin; Fei Han; Zhaoyang Cui
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Effects of glove finger- versus lidocaine-soaked nasal packing after endoscopic nasal surgery: a prospective randomized controlled trial.

Authors:  Massimiliano Garzaro; Valeria Dell'Era; Maria Silvia Rosa; Michele Cerasuolo; Giacomo Garzaro; Paolo Aluffi Valletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-26       Impact factor: 2.503

4.  Comparative analysis of Cutanplast and Spongostan nasal packing after endoscopic sinus surgery: a prospective, randomized, multicenter study.

Authors:  Kyu-Sup Cho; Chan-Hwi Park; Sung-Lyong Hong; Min-Jung Kim; Joo-Yeon Kim; Yong-Wan Kim; Soo-Kweon Koo; Hwan-Jung Roh
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-04       Impact factor: 2.503

5.  Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms.

Authors:  Lauren Martyn; Rishabh Sethia; Rachel Chon; Laura Novotny; Steven D Goodman; Charles Elmaraghy; Lauren O Bakaletz
Journal:  Laryngoscope       Date:  2019-07-17       Impact factor: 3.325

6.  Green hemostatic sponge-like scaffold composed of soy protein and chitin for the treatment of epistaxis.

Authors:  Jon Jimenez-Martin; Kevin Las Heras; Alaitz Etxabide; Jone Uranga; Koro de la Caba; Pedro Guerrero; Manoli Igartua; Edorta Santos-Vizcaino; Rosa Maria Hernandez
Journal:  Mater Today Bio       Date:  2022-04-30

7.  Antibodies directed against integration host factor mediate biofilm clearance from Nasopore.

Authors:  Kathleyn A Brandstetter; Joseph A Jurcisek; Steven D Goodman; Lauren O Bakaletz; Subinoy Das
Journal:  Laryngoscope       Date:  2013-05-13       Impact factor: 3.325

8.  Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model.

Authors:  Onat Akyol; Prativa Sherchan; Gokce Yilmaz; Cesar Reis; Wingi Man Ho; Yuechun Wang; Lei Huang; Ihsan Solaroglu; John H Zhang
Journal:  Exp Neurol       Date:  2018-06-05       Impact factor: 5.330

Review 9.  Biodegradable nasal packings for endoscopic sinonasal surgery: a systematic review and meta-analysis.

Authors:  Maoxiao Yan; Dandan Zheng; Ying Li; Qiaoli Zheng; Jia Chen; Beibei Yang
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

10.  Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.

Authors:  Brian A Bruckner; Lance N Blau; Limael Rodriguez; Erik E Suarez; Uy Q Ngo; Michael J Reardon; Matthias Loebe
Journal:  J Cardiothorac Surg       Date:  2014-08-02       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.